Cargando…

P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA

INTRODUCTION: On January 30th of 2020, the WHO declared the COVID-19 outbreak a health emergency. In Colombia the first case was reported on March 6th of 2020. The disease has unfavorable outcomes and mortality in patients with high risk factors like solid-organ transplant recipients. In Colombia th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez, Margarita, Pérez, Leonardo, Beltrán, Oscar, Garzón, Martín, Amaya, Alejandra, Salinas, Carolina, Hernández, Geovanny, Torres, Cristina, Rivera, Jairo, Murcia, Andrés, Mejía, Gilberto, Varón, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468378/
http://dx.doi.org/10.1016/j.aohep.2021.100468
_version_ 1784573652177518592
author Gutiérrez, Margarita
Pérez, Leonardo
Beltrán, Oscar
Garzón, Martín
Amaya, Alejandra
Salinas, Carolina
Hernández, Geovanny
Torres, Cristina
Rivera, Jairo
Murcia, Andrés
Mejía, Gilberto
Varón, Adriana
author_facet Gutiérrez, Margarita
Pérez, Leonardo
Beltrán, Oscar
Garzón, Martín
Amaya, Alejandra
Salinas, Carolina
Hernández, Geovanny
Torres, Cristina
Rivera, Jairo
Murcia, Andrés
Mejía, Gilberto
Varón, Adriana
author_sort Gutiérrez, Margarita
collection PubMed
description INTRODUCTION: On January 30th of 2020, the WHO declared the COVID-19 outbreak a health emergency. In Colombia the first case was reported on March 6th of 2020. The disease has unfavorable outcomes and mortality in patients with high risk factors like solid-organ transplant recipients. In Colombia the data of the behavior disease in liver transplant patients are limited. OBJECTIVES: To describe the prevalence, need of admission to hospital, complications and mortality of COVID-19 in liver transplant recipients. METHODS: A descriptive study of case series was performed from March 1st of 2020 to January 31(st) of 2021 in liver transplant recipients at Fundación Cardioinfantil-IC in Bogotá, Colombia. An analysis of clinical variables, severity laboratories, imaging and clinical follow-up were performed. Qualitative variables were described in percentage and quantitative variables were applied to a normality test using Kolmogorov Smirnov and Shapiro Wilk and the results were expressed as medians and IRQ or means and SD. RESULTS: Out of 540 adults liver transplant recipients on Fundación Cardioinfantil-IC, 34 patients (6.2%) were diagnosed with Covid 19, median age 62 years (IQR: 26), 20 (58%) male, 13 (38.2%) were admitted to hospitalization, and 4 (11.7%) required ICU. More frequent symptoms were fever in 17/34 patients (50%), cough in 17/34 (50%) and dyspnea 10/34 (29.4%). Ten patients (29.4%) had pneumonia as radiographic findings. Four patients required mechanical ventilation. Complications like acute renal injury were found in 3 patients, 1 patient required renal replacement therapy and 1 patient had gastrointestinal bleeding. 3 patients died (8.8%) on average 14 days of hospital length in ICU. CONCLUSION: Although the group of liver transplant patients is considered to be at high risk for unfavorable outcomes in SARS COV2 infection, the data on mortality and complications were similar to the few data described in the literature.
format Online
Article
Text
id pubmed-8468378
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier España, S.L.
record_format MEDLINE/PubMed
spelling pubmed-84683782021-09-27 P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA Gutiérrez, Margarita Pérez, Leonardo Beltrán, Oscar Garzón, Martín Amaya, Alejandra Salinas, Carolina Hernández, Geovanny Torres, Cristina Rivera, Jairo Murcia, Andrés Mejía, Gilberto Varón, Adriana Ann Hepatol Article INTRODUCTION: On January 30th of 2020, the WHO declared the COVID-19 outbreak a health emergency. In Colombia the first case was reported on March 6th of 2020. The disease has unfavorable outcomes and mortality in patients with high risk factors like solid-organ transplant recipients. In Colombia the data of the behavior disease in liver transplant patients are limited. OBJECTIVES: To describe the prevalence, need of admission to hospital, complications and mortality of COVID-19 in liver transplant recipients. METHODS: A descriptive study of case series was performed from March 1st of 2020 to January 31(st) of 2021 in liver transplant recipients at Fundación Cardioinfantil-IC in Bogotá, Colombia. An analysis of clinical variables, severity laboratories, imaging and clinical follow-up were performed. Qualitative variables were described in percentage and quantitative variables were applied to a normality test using Kolmogorov Smirnov and Shapiro Wilk and the results were expressed as medians and IRQ or means and SD. RESULTS: Out of 540 adults liver transplant recipients on Fundación Cardioinfantil-IC, 34 patients (6.2%) were diagnosed with Covid 19, median age 62 years (IQR: 26), 20 (58%) male, 13 (38.2%) were admitted to hospitalization, and 4 (11.7%) required ICU. More frequent symptoms were fever in 17/34 patients (50%), cough in 17/34 (50%) and dyspnea 10/34 (29.4%). Ten patients (29.4%) had pneumonia as radiographic findings. Four patients required mechanical ventilation. Complications like acute renal injury were found in 3 patients, 1 patient required renal replacement therapy and 1 patient had gastrointestinal bleeding. 3 patients died (8.8%) on average 14 days of hospital length in ICU. CONCLUSION: Although the group of liver transplant patients is considered to be at high risk for unfavorable outcomes in SARS COV2 infection, the data on mortality and complications were similar to the few data described in the literature. Published by Elsevier España, S.L. 2021-09 2021-09-26 /pmc/articles/PMC8468378/ http://dx.doi.org/10.1016/j.aohep.2021.100468 Text en Copyright © 2021 Published by Elsevier España, S.L. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gutiérrez, Margarita
Pérez, Leonardo
Beltrán, Oscar
Garzón, Martín
Amaya, Alejandra
Salinas, Carolina
Hernández, Geovanny
Torres, Cristina
Rivera, Jairo
Murcia, Andrés
Mejía, Gilberto
Varón, Adriana
P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA
title P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA
title_full P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA
title_fullStr P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA
title_full_unstemmed P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA
title_short P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA
title_sort p-108 coronavirus disease (covid-19) in liver transplant patients: a single center experience in bogotá colombia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468378/
http://dx.doi.org/10.1016/j.aohep.2021.100468
work_keys_str_mv AT gutierrezmargarita p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT perezleonardo p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT beltranoscar p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT garzonmartin p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT amayaalejandra p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT salinascarolina p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT hernandezgeovanny p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT torrescristina p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT riverajairo p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT murciaandres p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT mejiagilberto p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia
AT varonadriana p108coronavirusdiseasecovid19inlivertransplantpatientsasinglecenterexperienceinbogotacolombia